Exabis Library
Welcome to the e-CCO Library!
P454: Can calcineurin inhibitors induce a durable remission that is maintained with vedolizumab in IBD?
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P454: Combo-therapy in infliximab-resistant inflammatory bowel disease patients: data from a tertiary referral centre
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P454: Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P454: Evaluation of the nutritional care status in italian centers managing patients affected by inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P454: No increased postoperative risk of venous thromboembolism nor infectious complications after JAK inhibitor exposure in patients with ulcerative colitis undergoing colectomy
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P454: Prediction of endoscopic activity in patients with Crohn’s disease: systematic review and external validation of published prediction models
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P454: Treatment with biologics improves disability from Inflammatory Bowel Disease in therapy responders
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P455 Adherence to enteral nutrition therapy by adults with active Crohn’s disease is associated with conscientiousness personality trait
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P455: Aminosalicylates in Ulcerative Colitis: old but gold?
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P455: Clinical features of tuberculosis infection in inflammatory bowel disease patients on anti-TNF therapy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P455: Comparison of two strategies for the management of post-operative recurrence in Crohn's disease patients with one clinical risk factor: a multicentre IG-IBD study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P455: Evaluation of the optic nerve function in patients with ulcerative colitis and Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P455: Spacing of infliximab infusions over 8 weeks in patients with inflammatory bowel diseases in clinical remission: Final results of a retrospective multicentre French national cohort
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P455: The effect of concurrent HIV-1 infection on the management of patients with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P455: Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P456 Longer-term outcomes in acute severe colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P456: Comparative analysis of oral versus intravenous iron in patients with inflammatory bowel disease and iron deficiency/anaemia – impact on hospitalisation in Germany
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P456: Drug survival of thiopurine–allopurinol combination therapy in a real-life population-based cohort
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P456: Efficacy and safety of TNF antagonist for the treatment of internal fistulising Crohn’s disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P456: Ig glycosylation in ulcerative colitis: it's time for new biomarkers
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM